Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01718444 · ClinicalTrials.gov registry record · NA
Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01718444 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 27 participants.
The verdict
NCT01718444, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Progestin-induced endometrial shedding (PIES) followed by clomiphene citrate is fertility treatment of choice in anovulatory women with polycystic ovary syndrome (PCOS). However, some preliminary data suggest that skipping PIES could result in a higher live birth rate. The investigators are performing the first randomized controlled trial to find out if skipping the use of progestin during fertility treatment of anovulatory PCOS women is associated with improved pregnancy and live birth rates compared to the traditional approach of using progestin prior to use of clomiphene citrate.
Interventions
- DRUG Clomiphene Citrate
- DRUG Progestin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01718444
The ClinicalTrials.gov registry entry for NCT01718444 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clomiphene Citrate is the first listed.
NCT01718444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01718444 about?
NCT01718444 is a clinical study titled "Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)". Progestin-induced endometrial shedding (PIES) followed by clomiphene citrate is fertility treatment of choice in anovulatory women with polycystic ovary syndrome (PCOS). However, some preliminary data suggest that skipping PIES could result in a higher live birth rate. The investigators are performi...
What is the current status of trial NCT01718444?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2015-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01718444?
The interventions under investigation include: Clomiphene Citrate (DRUG), Progestin (DRUG).
Who is sponsoring clinical trial NCT01718444?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.